ENDONOVO THERAPEUTICS, INC. Quarterly Return On Assets in % from Q3 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Endonovo Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2012 to Q3 2023.
  • Endonovo Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -409 %, a 123% decline year-over-year.
  • Endonovo Therapeutics, Inc. annual Return On Assets for 2022 was -1.2K %, a 766% decline from 2021.
  • Endonovo Therapeutics, Inc. annual Return On Assets for 2021 was -139 %, a 892% decline from 2020.
  • Endonovo Therapeutics, Inc. annual Return On Assets for 2020 was -14 %, a 97.1% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -409 -225 -123% Jul 1, 2023 Sep 30, 2023
Q2 2023 -343 -128 -59.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -639 -501 -364% Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.2K -1.06K -766% Oct 1, 2022 Dec 31, 2022
Q3 2022 -183 +133 +42% Jul 1, 2022 Sep 30, 2022
Q2 2022 -215 +64 +22.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -138 +138 +50% Jan 1, 2022 Mar 31, 2022
Q4 2021 -139 -125 -892% Oct 1, 2021 Dec 31, 2021
Q3 2021 -316 -181 -134% Jul 1, 2021 Sep 30, 2021
Q2 2021 -279 -141 -102% Apr 1, 2021 Jun 30, 2021
Q1 2021 -276 +28.9 +9.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -14 +461 +97.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -135 +130 +49% Jul 1, 2020 Sep 30, 2020
Q2 2020 -138 +214 +60.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -305 -111 -57.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -475 -330 -227% Oct 1, 2019 Dec 31, 2019
Q3 2019 -264 -130 -97.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -352 -151 -75.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -193 -38.3 -24.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -145 +665 +82.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -134 +4.99K +97.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -200 +2.9K +93.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -155 +4.51K +96.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -811 +1.41K +63.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -5.12K -1.68K -49% Jul 1, 2017 Sep 30, 2017
Q2 2017 -3.1K +718 +18.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -4.67K -1.07K -29.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -2.22K +2.38K +51.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -3.44K +1.07K +23.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -3.82K Apr 1, 2016 Jun 30, 2016
Q1 2016 -3.6K Jan 1, 2016 Mar 31, 2016
Q4 2015 -4.59K Oct 1, 2015 Dec 31, 2015
Q3 2015 -4.51K Jul 1, 2015 Sep 30, 2015
Q4 2013 -3.64K -3.39K -1356% Oct 1, 2013 Dec 31, 2013
Q3 2013 -3.57K -3.39K -1895% Jul 1, 2013 Sep 30, 2013
Q2 2013 -919 Apr 1, 2013 Jun 30, 2013
Q1 2013 -488 Jan 1, 2013 Mar 31, 2013
Q4 2012 -250 Oct 1, 2012 Dec 31, 2012
Q3 2012 -179 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.